サンプル依頼リスト カート
  • English
  • Korean
デフォルト表紙
市場調査レポート
商品コード
1300889

ラジオセラノスティクスの世界市場規模調査＆予測：放射性同位体別、アプローチ別、用途別、地域別分析、2023-2030年

Global Radiotheranostics Market Size study & Forecast, by Radioisotope, by Approach, by Application by and Regional Analysis, 2023-2030
出版日: | 発行: Bizwit Research & Consulting LLP | ページ情報: 英文 | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
ラジオセラノスティクスの世界市場規模調査＆予測：放射性同位体別、アプローチ別、用途別、地域別分析、2023-2030年
出版日: 2023年06月19日
発行: Bizwit Research & Consulting LLP
ページ情報: 英文
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

ラジオセラノスティクスの世界市場は、2022年に約75億1,000万米ドルと評価され、予測期間2023-2030年には13.49%以上の堅調な成長率で成長すると予測されています。

ラジオセラノスティクスとは、放射性医薬品の治療と診断を組み合わせた医療分野のことで、標的を絞った放射線療法と画像診断技術を用いることで、個別化治療戦略を可能にします。ラジオセラノスティクス市場は、がん患者の増加や注射可能な放射性医薬品の採用増加などの要因によって牽引されています。

ラジオセラノスティクス（Radiotheranostics）は、がん管理に個別化された標的アプローチを提供します。国際がん研究機関によると、世界では2018年に1,700万人の新規がん患者が発生し、2040年には2,750万人の新規がん患者が発生すると推定されています。このように、がん患者の増加が市場の成長を後押ししています。また、新規ラジオセラノスティクスの承認が増加し、研究に対する官民の資金援助が増加することで、市場に有利な機会が生まれる可能性があります。しかし、研究開発にかかるコストが高いため、市場拡大の妨げになる可能性があります。

世界のラジオセラノスティクス市場の調査対象となる主な地域は、アジア太平洋、北米、欧州、ラテンアメリカ、中東・アフリカなどです。北米は、過体重人口の増加や多くの市場プレイヤーの採用増加により、ラジオTheranostics市場で主要なシェアを占めています。アジア太平洋は、その大規模な患者ベースとがんのその上昇orevlanceと一緒に高投資核医学のため、最も急成長している市場を検討しています。

本調査の目的は、近年におけるさまざまなセグメントと国の市場規模を明らかにし、今後数年間の市場規模を予測することです。本レポートは、調査対象国における産業の質的・量的側面を盛り込むよう設計されています。

また、市場の将来的な成長を規定する促進要因や課題などの重要な側面に関する詳細情報も提供しています。さらに、主要企業の競合情勢や製品提供の詳細な分析とともに、利害関係者が投資するためのミクロ市場における潜在的な機会も組み込んでいます。

目次

第1章 エグゼクティブサマリー

  • 市場スナップショット
  • 世界市場・セグメント別市場推計・予測、2020-2030年
    • ラジオセラノスティクス市場：地域別、2020-2030年
    • ラジオセラノスティクス市場：放射性同位体別、2020-2030年
    • ラジオセラノスティクス市場：アプローチ別、2020-2030年
    • ラジオセラノスティクス市場：用途別、2020-2030年
  • 主要動向
  • 調査手法
  • 調査前提条件

第2章 ラジオセラノスティクスの世界市場：定義と範囲

  • 調査目的
  • 市場の定義と範囲
    • 産業の進化
    • 調査範囲
  • 調査対象年
  • 通貨換算レート

第3章 ラジオセラノスティクスの世界市場力学

  • ラジオセラノスティクス市場の影響分析（2020-2030年）
    • 市場促進要因
      • がん患者の増加
      • 注射用放射性医薬品の採用増加
    • 市場の課題
      • 研究開発コストの高さ
    • 市場機会
      • 新規放射性医薬品の承認の増加。
      • 研究開発に対する官民資金の増加

第4章 ラジオセラノスティクスの世界市場：産業分析

  • ポーターの5フォースモデル
    • 供給企業の交渉力
    • 買い手の交渉力
    • 新規参入業者の脅威
    • 代替品の脅威
    • 競争企業間の敵対関係
  • ポーターの5フォース影響分析
  • PEST分析
    • 政治
    • 経済
    • 社会
    • 技術
    • 環境
    • 法律
  • 主な投資機会
  • 主要成功戦略
  • COVID-19影響分析
  • 破壊的動向
  • 業界専門家の視点
  • アナリストの結論・提言

第5章 ラジオセラノスティクスの世界市場：放射性同位体別

  • 市場スナップショット
  • ラジオセラノスティクスの世界市場：放射性同位体別、実績- ポテンシャル分析
  • ラジオセラノスティクスの世界市場：放射性同位体別、推計・予測、2020-2030年
  • 放射性医薬品市場、サブセグメント分析
    • ヨウ素-131
    • ヨウ素-123
    • ガリウム-68
    • ルテチウム-177
    • 18FとY-90
    • その他

第6章 ラジオセラノスティクスの世界市場：アプローチ別

  • 市場スナップショット
  • ラジオセラノスティクスの世界市場：アプローチ別、実績- ポテンシャル分析
  • ラジオセラノスティクスの世界市場：アプローチ別、推定・予測、2020-2030年
  • ラジオセラノスティクス市場、サブセグメント別分析
    • 標的治療薬
    • ターゲット診断

第7章 ラジオセラノスティクスの世界市場：用途別

  • 市場スナップショット
  • ラジオセラノスティクスの世界市場：用途別、実績- ポテンシャル分析
  • ラジオセラノスティクスの世界市場：用途別、推定・予測、2020-2030年
  • ラジオセラノスティクス市場、サブセグメント分析
    • 腫瘍学
    • 非腫瘍学

第8章 ラジオセラノスティクスの世界市場：地域別分析

  • 主要国
  • 主な新興国
  • ラジオセラノスティクス市場、市場スナップショット、地域別
  • 北米
    • 米国
      • 放射性同位体別の推定・予測、2020-2030年
      • アプローチ別の推定・予測、2020-2030年
      • アプリケーション別の推定・予測、2020-2030年
    • カナダ
  • 欧州のラジオセラノスティクス市場スナップショット
    • 英国
    • ドイツ
    • フランス
    • スペイン
    • イタリア
    • その他欧州
  • アジア太平洋のラジオセラノスティクス市場のスナップショット
    • 中国
    • インド
    • 日本
    • オーストラリア
    • 韓国
    • その他アジア太平洋地域
  • ラテンアメリカのラジオセラノスティクス市場スナップショット
    • ブラジル
    • メキシコ
  • 中東・アフリカ
    • サウジアラビア
    • 南アフリカ
    • その他中東とアフリカ

第9章 競合情報

  • 主要企業のSWOT分析
  • 主要市場戦略
  • 企業プロファイル
    • Novartis AG
      • 主要情報
      • 概要
      • 財務（データの入手可能性によります）
      • 製品概要
      • 最近の動向
    • Bayer AG
    • Progenics Pharmaceuticals Inc.
    • Telix Pharmaceuticals
    • ITM Isotope Technologies Munich SE
    • Life molecular imaging
    • Radiomedix Inc.
    • Iso Therapeutics Group,LLC
    • Q Bio med Inc.
    • Nordic nanovector ASA

第10章 調査プロセス

  • 調査プロセス
    • データマイニング
    • 分析
    • 市場推定
    • 検証
    • 出版
  • 調査属性
  • 調査前提条件
図表

LIST OF TABLES

  • TABLE 1. Global Radiotheranostics Market, report scope
  • TABLE 2. Global Radiotheranostics Market estimates & forecasts by Region 2020-2030 (USD Billion)
  • TABLE 3. Global Radiotheranostics Market estimates & forecasts by Radioisotope 2020-2030 (USD Billion)
  • TABLE 4. Global Radiotheranostics Market estimates & forecasts by Approach 2020-2030 (USD Billion)
  • TABLE 5. Global Radiotheranostics Market estimates & forecasts by Application 2020-2030 (USD Billion)
  • TABLE 6. Global Radiotheranostics Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 7. Global Radiotheranostics Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 8. Global Radiotheranostics Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 9. Global Radiotheranostics Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 10. Global Radiotheranostics Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 11. Global Radiotheranostics Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 12. Global Radiotheranostics Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 13. Global Radiotheranostics Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 14. Global Radiotheranostics Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 15. Global Radiotheranostics Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 16. U.S. Radiotheranostics Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 17. U.S. Radiotheranostics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 18. U.S. Radiotheranostics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 19. Canada Radiotheranostics Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 20. Canada Radiotheranostics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 21. Canada Radiotheranostics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 22. UK Radiotheranostics Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 23. UK Radiotheranostics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 24. UK Radiotheranostics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 25. Germany Radiotheranostics Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 26. Germany Radiotheranostics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 27. Germany Radiotheranostics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 28. France Radiotheranostics Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 29. France Radiotheranostics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 30. France Radiotheranostics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 31. Italy Radiotheranostics Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 32. Italy Radiotheranostics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 33. Italy Radiotheranostics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 34. Spain Radiotheranostics Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 35. Spain Radiotheranostics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 36. Spain Radiotheranostics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 37. RoE Radiotheranostics Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 38. RoE Radiotheranostics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 39. RoE Radiotheranostics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 40. China Radiotheranostics Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 41. China Radiotheranostics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 42. China Radiotheranostics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 43. India Radiotheranostics Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 44. India Radiotheranostics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 45. India Radiotheranostics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 46. Japan Radiotheranostics Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 47. Japan Radiotheranostics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 48. Japan Radiotheranostics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 49. South Korea Radiotheranostics Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 50. South Korea Radiotheranostics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 51. South Korea Radiotheranostics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 52. Australia Radiotheranostics Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 53. Australia Radiotheranostics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 54. Australia Radiotheranostics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 55. RoAPAC Radiotheranostics Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 56. RoAPAC Radiotheranostics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 57. RoAPAC Radiotheranostics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 58. Brazil Radiotheranostics Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 59. Brazil Radiotheranostics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 60. Brazil Radiotheranostics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 61. Mexico Radiotheranostics Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 62. Mexico Radiotheranostics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 63. Mexico Radiotheranostics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 64. RoLA Radiotheranostics Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 65. RoLA Radiotheranostics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 66. RoLA Radiotheranostics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 67. Saudi Arabia Radiotheranostics Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 68. South Africa Radiotheranostics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 69. RoMEA Radiotheranostics Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 70. List of secondary sources, used in the study of global Radiotheranostics Market
  • TABLE 71. List of primary sources, used in the study of global Radiotheranostics Market
  • TABLE 72. Years considered for the study
  • TABLE 73. Exchange rates considered

List of tables and figures are dummy in nature, final lists may vary in the final deliverable

LIST OF FIGURES

  • FIG 1. Global Radiotheranostics Market, research methodology
  • FIG 2. Global Radiotheranostics Market, Market estimation techniques
  • FIG 3. Global Market size estimates & forecast methods
  • FIG 4. Global Radiotheranostics Market, key trends 2022
  • FIG 5. Global Radiotheranostics Market, growth prospects 2023-2030
  • FIG 6. Global Radiotheranostics Market, porters 5 force model
  • FIG 7. Global Radiotheranostics Market, pest analysis
  • FIG 8. Global Radiotheranostics Market, value chain analysis
  • FIG 9. Global Radiotheranostics Market by segment, 2020 & 2030 (USD Billion)
  • FIG 10. Global Radiotheranostics Market by segment, 2020 & 2030 (USD Billion)
  • FIG 11. Global Radiotheranostics Market by segment, 2020 & 2030 (USD Billion)
  • FIG 12. Global Radiotheranostics Market by segment, 2020 & 2030 (USD Billion)
  • FIG 13. Global Radiotheranostics Market by segment, 2020 & 2030 (USD Billion)
  • FIG 14. Global Radiotheranostics Market, regional snapshot 2020 & 2030
  • FIG 15. North America Radiotheranostics Market 2020 & 2030 (USD Billion)
  • FIG 16. Europe Radiotheranostics Market 2020 & 2030 (USD Billion)
  • FIG 17. Asia pacific Radiotheranostics Market 2020 & 2030 (USD Billion)
  • FIG 18. Latin America Radiotheranostics Market 2020 & 2030 (USD Billion)
  • FIG 19. Middle East & Africa Radiotheranostics Market 2020 & 2030 (USD Billion)

List of tables and figures are dummy in nature, final lists may vary in the final deliverable

目次

Global Radiotheranostics Market is valued at approximately USD 7.51 billion in 2022 and is anticipated to grow with a healthy growth rate of more than 13.49% over the forecast period 2023-2030. Radiotheranostics refers to the field of medicine that combine the therapeutic and diagnostic application of radiopharmaceuticals enabling personalized treatment strategies by using targeted radiation therapy and imaging techniques. The Radiotheranostics market is being driven by factors such as the Increasing prevalence of cancer cases and the rising adoption of injectable radiopharmaceuticals.

Radiotheranostics offers a personalized and targeted approach to cancer management. By combining diagnostic imaging with therapeutic interventions, it enhances precision, improves treatment outcomes, reduces side effects, and enables personalized therapies based on individual patients' characteristics and disease biology.According to the International Agency for Research on Cancer, Worldwide, an estimated 17 million new cancer cases in 2018 and it is estimated to rise by 27.5 million new cancer cases in 2040. Thus, rising in cancer cases fueling the market growth. In addition, increasing the approvals of new radiotheranostics agents and increasing public-private funding for research may create lucrative opportunities for the market. However, market expansion may hinder due to the high cost involved in research and development.

The key regions considered for the Global RadiotheranosticsMarket study includes Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America holds the major share in radio theranostics market due to the rising overweight population and also rising adoption of large number of market players. Asia Pacific consider fastest growing market due to its large patient base and high investing nuclear medicine along with that rising orevlance of cancer.

Major market players included in this report are:

  • Novartis AG
  • Bayer AG
  • Progenics Pharmaceuticals, Inc.( Lantheus)
  • Telix Pharmaceuticals Limited.
  • ITM Isotope Technologies Munich SE
  • Life Molecular Imaging.
  • RadioMedix Inc.
  • IsoTherapeutics Group, LLC
  • Q BioMed Inc.
  • Nordic Nanovector ASA

Recent Developments in the Market:

  • On May 2022, Transcode therapeutics Inc. announced the execution of an option agreement under which transcode will have the right to negotiate an exclusive, world, royalty-bearing licence for a radiotheranostic technology disclosed in patent application PCT/US2021/057912 Entitled THERAPEUTICS, RADIOLABLED NANOPARTICLES AND METHOD OF USE THEREOF.
  • On Oct 2022, Clarity pharmaceuticals announced that the first patient in its phase1/2theranostic trial, which is testing 64Cu/67Cu SAR-bisPSMA theranostic product in people with metastatic castrate-restant prostate cancer, has been given a dose. The promising preclinical and clinical result so far support clarity's investigation of the optimised SAR-bisPSMA product in additional oncology indications where the theranostic approach may be useful.

Global RadiotheranosticsMarket Report Scope:

  • Historical Data: 2020 - 2021
  • Base Year for Estimation: 2022
  • Forecast period: 2023-2030
  • Report Coverage: Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
  • Segments Covered: Radioisotope, Approach, Application, Region
  • Regional Scope: North America; Europe; Asia Pacific; Latin America; Middle East & Africa
  • Customization Scope: Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Radioisotope:

  • Iodine-131
  • Iodine-123
  • Gallium-68
  • Lutetium-177
  • 18F with Y-90
  • Others

By Approach:

  • Targeted Therapeutic
  • Targeted Diagnostic

Application:

  • Oncology
  • Non Oncology

By Region:

  • North America
  • U.S.
  • Canada
  • Europe
  • UK
  • Germany
  • France
  • Spain
  • Italy
  • ROE
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • RoAPAC
  • Latin America
  • Brazil
  • Mexico
  • Middle East & Africa
  • Saudi Arabia
  • South Africa
  • Rest of Middle East & Africa

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Billion)
    • 1.2.1. Radiotheranostics Market, by Region, 2020-2030 (USD Billion)
    • 1.2.2. Radiotheranostics Market, by Radioisotope, 2020-2030 (USD Billion)
    • 1.2.3. Radiotheranostics Market, by Approach, 2020-2030 (USD Billion)
    • 1.2.4. Radiotheranostics Market, by Application, 2020-2030 (USD Billion)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global Radiotheranostics Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Industry Evolution
    • 2.2.2. Scope of the Study
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global Radiotheranostics Market Dynamics

  • 3.1. Radiotheranostics Market Impact Analysis (2020-2030)
    • 3.1.1. Market Drivers
      • 3.1.1.1. Increasing prevalence of cancer cases.
      • 3.1.1.2. Rising adoption of injectable radiopharmaceuticals.
    • 3.1.2. Market Challenges
      • 3.1.2.1. High cost involved in research and development.
    • 3.1.3. Market Opportunities
      • 3.1.3.1. Increasing the approvals of new radiotheranostics agents.
      • 3.1.3.2. Increasing public-private funding for research and development.

Chapter 4. Global Radiotheranostics Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
  • 4.2. Porter's 5 Force Impact Analysis
  • 4.3. PEST Analysis
    • 4.3.1. Political
    • 4.3.2. Economical
    • 4.3.3. Social
    • 4.3.4. Technological
    • 4.3.5. Environmental
    • 4.3.6. Legal
  • 4.4. Top investment opportunity
  • 4.5. Top winning strategies
  • 4.6. COVID-19 Impact Analysis
  • 4.7. Disruptive Trends
  • 4.8. Industry Expert Perspective
  • 4.9. Analyst Recommendation & Conclusion

Chapter 5. Global Radiotheranostics Market, by Radioisotope

  • 5.1. Market Snapshot
  • 5.2. Global Radiotheranostics Market by Radioisotope, Performance - Potential Analysis
  • 5.3. Global Radiotheranostics Market Estimates & Forecasts by Radioisotope 2020-2030 (USD Billion)
  • 5.4. Radiotheranostics Market, Sub Segment Analysis
    • 5.4.1. Iodine-131
    • 5.4.2. Iodine-123
    • 5.4.3. Gallium-68
    • 5.4.4. Lutetium-177
    • 5.4.5. 18F with Y-90
    • 5.4.6. Others

Chapter 6. Global Radiotheranostics Market, by Approach

  • 6.1. Market Snapshot
  • 6.2. Global Radiotheranostics Market by Approach, Performance - Potential Analysis
  • 6.3. Global Radiotheranostics Market Estimates & Forecasts by Approach 2020-2030 (USD Billion)
  • 6.4. Radiotheranostics Market, Sub Segment Analysis
    • 6.4.1. Targeted therapeutic
    • 6.4.2. Targeted Diagnostic

Chapter 7. Global Radiotheranostics Market, by Application

  • 7.1. Market Snapshot
  • 7.2. Global Radiotheranostics Market by Application, Performance - Potential Analysis
  • 7.3. Global Radiotheranostics Market Estimates & Forecasts by Application 2020-2030 (USD Billion)
  • 7.4. Radiotheranostics Market, Sub Segment Analysis
    • 7.4.1. Oncology
    • 7.4.2. Non-oncology

Chapter 8. Global Radiotheranostics Market, Regional Analysis

  • 8.1. Top Leading Countries
  • 8.2. Top Emerging Countries
  • 8.3. Radiotheranostics Market, Regional Market Snapshot
  • 8.4. North America Radiotheranostics Market
    • 8.4.1. U.S. Radiotheranostics Market
      • 8.4.1.1. Radioisotope breakdown estimates & forecasts, 2020-2030
      • 8.4.1.2. Approach breakdown estimates & forecasts, 2020-2030
      • 8.4.1.3. Application breakdown estimates & forecasts, 2020-2030
    • 8.4.2. Canada Radiotheranostics Market
  • 8.5. Europe Radiotheranostics Market Snapshot
    • 8.5.1. U.K. Radiotheranostics Market
    • 8.5.2. Germany Radiotheranostics Market
    • 8.5.3. France Radiotheranostics Market
    • 8.5.4. Spain Radiotheranostics Market
    • 8.5.5. Italy Radiotheranostics Market
    • 8.5.6. Rest of Europe Radiotheranostics Market
  • 8.6. Asia-Pacific Radiotheranostics Market Snapshot
    • 8.6.1. China Radiotheranostics Market
    • 8.6.2. India Radiotheranostics Market
    • 8.6.3. Japan Radiotheranostics Market
    • 8.6.4. Australia Radiotheranostics Market
    • 8.6.5. South Korea Radiotheranostics Market
    • 8.6.6. Rest of Asia Pacific Radiotheranostics Market
  • 8.7. Latin America Radiotheranostics Market Snapshot
    • 8.7.1. Brazil Radiotheranostics Market
    • 8.7.2. Mexico Radiotheranostics Market
  • 8.8. Middle East & Africa Radiotheranostics Market
    • 8.8.1. Saudi Arabia Radiotheranostics Market
    • 8.8.2. South Africa Radiotheranostics Market
    • 8.8.3. Rest of Middle East & Africa Radiotheranostics Market

Chapter 9. Competitive Intelligence

  • 9.1. Key Company SWOT Analysis
    • 9.1.1. Company 1
    • 9.1.2. Company 2
    • 9.1.3. Company 3
  • 9.2. Top Market Strategies
  • 9.3. Company Profiles
    • 9.3.1. Novartis AG
      • 9.3.1.1. Key Information
      • 9.3.1.2. Overview
      • 9.3.1.3. Financial (Subject to Data Availability)
      • 9.3.1.4. Product Summary
      • 9.3.1.5. Recent Developments
    • 9.3.2. Bayer AG
    • 9.3.3. Progenics Pharmaceuticals Inc.
    • 9.3.4. Telix Pharmaceuticals
    • 9.3.5. ITM Isotope Technologies Munich SE
    • 9.3.6. Life molecular imaging
    • 9.3.7. Radiomedix Inc.
    • 9.3.8. Iso Therapeutics Group,LLC
    • 9.3.9. Q Bio med Inc.
    • 9.3.10. Nordic nanovector ASA

Chapter 10. Research Process

  • 10.1. Research Process
    • 10.1.1. Data Mining
    • 10.1.2. Analysis
    • 10.1.3. Market Estimation
    • 10.1.4. Validation
    • 10.1.5. Publishing
  • 10.2. Research Attributes
  • 10.3. Research Assumption